Abstract
HIV-1 Env pseudotyped viruses (PV) are an attractive tool for studying the antiviral activities of compounds interfering with virus entry into a target cell. To investigate whether results obtained in PV assays are relevant biologically, the antiviral activity of 6 reference compounds was compared on 5 virus isolates of different clades using three assays: (1) replicating virus in peripheral blood mononuclear cells (PBMCs), (2) PV in CD4 and CCR5- or CXCR4 co-receptor expressing Ghost cells, and (3) PV in PBMCs. A significant linear relationship was found between both single-cycle PV assays (P<0.0001, R2=0.75). Moreover, both assays showed enhanced sensitivity to the antiretrovirals tested (P=0.013 and 0.015, respectively) as compared to the PBMC assay with replication-competent virus. Most importantly, results from the latter assay could be predicted significantly from both PV assays, in which either Ghost target cells (P<0.0001, R2=0.61) or PBMCs (P<0.0001, R2=0.55) were used. The usefulness of the PV assay was demonstrated further by investigating the impact of the HIV-1 Env subtype on the antiviral activity of five new compounds derived from the entry inhibitor BMS806.
References
Feb 1, 1995·AIDS Research and Human Retroviruses·P ZhongG van der Groen
Aug 15, 1998·Journal of Virological Methods·E BeirnaertG van der Groen
May 23, 2002·Antimicrobial Agents and Chemotherapy·Xiping WeiJohn C Kappes
Dec 19, 2002·AIDS Research and Human Retroviruses·Shi-Hua XiangJames E Robinson
Aug 22, 2003·Proceedings of the National Academy of Sciences of the United States of America·Pin-Fang LinRichard Colonno
Sep 23, 2003·Journal of Medical Primatology·M HsuC Cheng-Mayer
Mar 16, 2004·Journal of Virology·Navid MadaniJoseph G Sodroski
May 17, 2005·Drugs·Antonella CastagnaAdriano Lazzarin
Jul 12, 2005·Virology·Mark K LouderJohn R Mascola
Feb 9, 2006·The Journal of Antimicrobial Chemotherapy·Verónica BrizVincent Soriano
Feb 24, 2006·Virology·Christoph SeibertThomas P Sakmar
Mar 7, 2006·Current Pharmaceutical Design·Ingrid Markovic
Apr 14, 2006·Current Medicinal Chemistry·J Thomas Leonard, Kunal Roy
Jun 7, 2006·Antiviral Research·Dominique Schols
Aug 15, 2006·Biochemical and Biophysical Research Communications·Vidita ChoudhryDimiter S Dimitrov
Dec 22, 2006·Journal of Virology·Mike WestbyManos Perros
Mar 6, 2007·Lancet·Jan Balzarini, Lut Van Damme
Apr 13, 2007·Virology·Thomas J KetasJohn P Moore
Citations
Nov 11, 2011·Pharmaceutical Research·José das NevesBruno Sarmento
Dec 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Alonso HerediaRobert R Redfield
Jun 19, 2009·Journal of Virology·Nicholas M ProvineNancy L Haigwood
Feb 21, 2009·PloS One·Eva Maria FenyöGabriella Scarlatti
Apr 13, 2011·PloS One·Ji WangYing-hua Chen
Oct 22, 2011·PloS One·Sunita S Balla-JhagjhoorsinghGuido Vanham
May 17, 2012·PloS One·Leo HeyndrickxGabriella Scarlatti
Jun 6, 2012·PloS One·Ellen Van GulckGuido Vanham
Jul 23, 2013·PloS One·Sunita S Balla-JhagjhoorsinghGuido Vanham
Jun 9, 2009·Antiviral Research·Olga LatinovicRobert R Redfield
Sep 24, 2011·Vaccine·Ji WangYing-Hua Chen
May 29, 2018·FEBS Letters·Shuwen YinLin Li
Jan 1, 2017·Journal of Nanotechnology and Materials Science·Karl KhandalavalaAnnemarie Shibata